Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02038647
Title Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Los Angeles California United States Details
Sacramento California United States Details
New Haven Connecticut United States Details
Washington District of Columbia United States Details
Boca Raton Florida United States Details
Hollywood Florida United States Details
Orlando Florida United States Details
Tampa Florida United States Details
Atlanta Georgia United States Details
Chicago Illinois United States Details
Boston Massachusetts United States Details
Ann Arbor Michigan United States Details
Detroit Michigan United States Details
Minneapolis Minnesota United States Details
Cleveland Ohio United States Details
Hershey Pennsylvania United States Details
Philadelphia Pennsylvania United States Details
Pittsburgh Pennsylvania United States Details
Nashville Tennessee United States Details
Houston Texas United States Details
Seattle Washington United States Details
Edegem Belgium Details
Gent Belgium Details
Kortrijk Belgium Details
Leuven Belgium Details
Mons Belgium Details
Roeselare Belgium Details
Edmonton Alberta Canada Details
Hamilton Ontario Canada Details
Greenfield Park Canada Details
Olomouc Czechia Details
Ostrava Czechia Details
Praha Czechia Details
Usti Nad Labem Czechia Details
Grenoble France Details
Lyon France Details
Marseille France Details
Paris France Details
Pessac France Details
Rennes France Details
Berlin Germany Details
Frankfurt Germany Details
Freiburg Germany Details
Luebeck Germany Details
Budapest Hungary Details
Farkasgyepu Hungary Details
Szolnok Hungary Details
Tatabanya Hungary Details
Torokbalint Hungary Details
Milano Italy Details
Orbassano Italy Details
Parma Italy Details
Gdansk Poland Details
Mrozy Poland Details
Warszawa Poland Details
Wodzislaw Slaski Poland Details
A Coruna Spain Details
Barcelona Spain Details
Girona Spain Details
Madrid Spain Details
Sevilla Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field